Medical debt returns to credit reports
Consumers were dealt a blow when a federal judge in Texas tossed out a Biden-era rule that would have banned the inclusion of medical debt on credit reports.
In a move that arguably eliminates a vital consumer protection, U.S. District Judge Sean Jordan on July 11 granted a request from President Donald Trump's administration and industry groups to vacate the medical debt rule.
Here's what it means for consumers.
No more pizza at the office?
If your company provides free office snacks or meals, that perk could be at risk due to President Trump's new tax law.
A tax deduction offered to employers for takeout meals and company-provided cafeteria meals will expire at the end of this year, thanks to a provision in the so-called "Big Beautiful Bill", which became law earlier in July.
Does that mean no more pizza on long work nights?
📰 More stories you shouldn't miss 📰
🍔 Today's Menu 🍔
An April Fool's joke made by a fast-food fan account wound up in a White House Press release on Monday.
In a since-modified statement, the Trump administration touted recent changes made by major food and beverage companies in response to the administration's "Make America Healthy Again" initiative. Among the announcements: a bullet point claiming that California-based fast food chain In-N-Out "transitioned to 100% beef tallow."
Alas, it was all a joke.
About The Daily Money
Each weekday, The Daily Money delivers the best consumer and financial news from USA TODAY, breaking down complex events, providing the TLDR version, and explaining how everything from Fed rate changes to bankruptcies impacts you.
Daniel de Visé covers personal finance for USA Today.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Declining Stock and Solid Fundamentals: Is The Market Wrong About Filtronic plc (LON:FTC)?
Explore Filtronic's Fair Values from the Community and select yours With its stock down 21% over the past month, it is easy to disregard Filtronic (LON:FTC). However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. In this article, we decided to focus on Filtronic's ROE. Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In simpler terms, it measures the profitability of a company in relation to shareholder's equity. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How Is ROE Calculated? ROE can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Filtronic is: 40% = UK£14m ÷ UK£35m (Based on the trailing twelve months to May 2025). The 'return' refers to a company's earnings over the last year. One way to conceptualize this is that for each £1 of shareholders' capital it has, the company made £0.40 in profit. See our latest analysis for Filtronic What Is The Relationship Between ROE And Earnings Growth? So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes. Filtronic's Earnings Growth And 40% ROE To begin with, Filtronic has a pretty high ROE which is interesting. Secondly, even when compared to the industry average of 11% the company's ROE is quite impressive. Under the circumstances, Filtronic's considerable five year net income growth of 76% was to be expected. We then compared Filtronic's net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 7.1% in the same 5-year period. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. Is Filtronic fairly valued compared to other companies? These 3 valuation measures might help you decide. Is Filtronic Making Efficient Use Of Its Profits? Given that Filtronic doesn't pay any regular dividends to its shareholders, we infer that the company has been reinvesting all of its profits to grow its business. Conclusion On the whole, we feel that Filtronic's performance has been quite good. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. With that said, on studying the latest analyst forecasts, we found that while the company has seen growth in its past earnings, analysts expect its future earnings to shrink. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Shareholders in Spirax Group (LON:SPX) are in the red if they invested three years ago
Explore Spirax Group's Fair Values from the Community and select yours For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term Spirax Group plc (LON:SPX) shareholders, since the share price is down 46% in the last three years, falling well short of the market return of around 62%. Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. Spirax Group saw its EPS decline at a compound rate of 6.6% per year, over the last three years. The share price decline of 19% is actually steeper than the EPS slippage. So it's likely that the EPS decline has disappointed the market, leaving investors hesitant to buy. The image below shows how EPS has tracked over time (if you click on the image you can see greater detail). We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. Dive deeper into the earnings by checking this interactive graph of Spirax Group's earnings, revenue and cash flow. What About Dividends? As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for Spirax Group the TSR over the last 3 years was -43%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence! A Different Perspective While the broader market gained around 22% in the last year, Spirax Group shareholders lost 18% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 7% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Spirax Group has 1 warning sign we think you should be aware of. Spirax Group is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
an hour ago
- Yahoo
EnBW Energie Baden-Württemberg Second Quarter 2025 Earnings: €0.34 loss per share (vs €2.00 profit in 2Q 2024)
Explore EnBW Energie Baden-Württemberg's Fair Values from the Community and select yours EnBW Energie Baden-Württemberg (ETR:EBK) Second Quarter 2025 Results Key Financial Results Revenue: €8.12b (down 8.7% from 2Q 2024). Net loss: €91.0m (down by 117% from €541.9m profit in 2Q 2024). €0.34 loss per share (down from €2.00 profit in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period EnBW Energie Baden-Württemberg shares are down 2.2% from a week ago. Risk Analysis You should learn about the 4 warning signs we've spotted with EnBW Energie Baden-Württemberg (including 2 which are a bit concerning). Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
